Year Established :
2009
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
500-1000
Main Competitive Advantages :
Brand Name,Experienced R&D Staff,Production Capacity,Reputation,Quality Service
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Western Europe,Eastern Europe,Asia,Africa
Product Range :
Ensured with technical know-how and patents, the Aidea team actively develops and sells Ulinastatin (Urinary Trypsin Inhibitor), Urokinase, Urinary Kallidinogenase, Ainuovirine, Senna Folium Granule to the domestic and international market.